✨ Free AI Report
Vistin Pharma ASA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Vistin Pharma ASA
Research Preview

Vistin Pharma ASA: Business Overview, Financials & Competitive Analysis

Vistin Pharma is Europe's sole dedicated Metformin Hydrochloride (HCl) producer, supplying leading international pharmaceutical companies. The company is doubling its production capacity to supply the growing need for...

Analyst-debate audio for Vistin Pharma ASA

AskCyborg analysts argue the bull and bear cases for Vistin Pharma ASA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Vistin Pharma ASA OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Focused pharmaceutical ingredients player capturing growing global diabetes market with strong balance sheet and unique European...

Read the full analyst-debate transcript →
Industry Pharmaceutical Active Pharmaceutical Ingredients (API) Manufacturing
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Vistin Pharma ASA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Vistin Pharma ASA Overview

Pro stress-test →

Vistin Pharma is Europe's sole dedicated Metformin Hydrochloride (HCl) producer, supplying leading international pharmaceutical companies. The company is doubling its production capacity to supply the growing need for Type 2 diabetes medicine globally.

Strategic Profile

Pro stress-test →

As a well-positioned sole European supplier, Vistin holds a defensible market position with exclusive geographic focus. The company maintains a strong balance sheet with an 81% equity ratio and net cash position. Revenue grew 44% year-over-year to NOK 438 million in 2023, demonstrating robust market demand for diabetes treatments.

Competitive Landscape

Pro stress-test →

Vistin operates in the pharmaceutical active pharmaceutical ingredients (API) market with minimal direct competitors in Europe for Metformin HCl production. Primary competition comes from non-European producers, primarily in Asia. The company's exclusive geographic positioning and FDA-inspected manufacturing facilities provide significant competitive barriers.

Industry Context

Vistin Pharma ASA operates in Pharmaceutical Active Pharmaceutical Ingredients (API) Manufacturing.

Key facts

Headquarters: Oslo, Norway · Revenue: NOK 438M (2023) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Vistin Pharma ASA.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Vistin Pharma ASA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Metformin Hydrochloride APIGlobal Metformin producers based primarily in China and India→

Compare Vistin Pharma ASA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Vistin Pharma ASA operates in Pharmaceutical Active Pharmaceutical Ingredients (API) Manufacturing. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Active Pharmaceutical Ingredients (API) Manufacturing research →
NEW · MCP server

Ask your AI assistant about Vistin Pharma ASA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Vistin Pharma ASA and its top competitor on Cyborg Score”
“What did Vistin Pharma ASA do this quarter?”
“Is Vistin Pharma ASA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Vistin Pharma ASA do?+
Vistin Pharma is Europe's sole dedicated Metformin Hydrochloride (HCl) producer, supplying leading international pharmaceutical companies. The company is doubling its production capacity to supply the growing need for...
What is Vistin Pharma ASA's Cyborg Score?+
Vistin Pharma ASA has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Vistin Pharma ASA's main competitors?+
Named competitors include Metformin Hydrochloride API. The full competitive landscape is in the AskCyborg report.
How can I get the full Vistin Pharma ASA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Vistin Pharma ASA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Vistin Pharma ASA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC